Recent Stories
American Biotech — The Future Can’t Be Won Without It.RSI is AI Building AI. What DC needs to know about it. Keeping the Human in Medicine: Two AI CoLab Researchers on What Machines Can’t ReplaceSomeone Is Hacking the Freezers. Pay Attention.Thinking of Running in 2028? Start HereWhat the Lame Duck Session Has to Do With the Ultimate 21st-Century Power Tool: Robots

The Wave

Senatein sessionHousein session
Refreshed just now
All24 hours
× Show allIn focus

FDA seeks comment on early-phase solid tumor trial guidance

FDA published a draft guidance on Nov. 12 giving sponsors recommendations for early-phase IND protocols for solid tumor drugs and biologics. Public comments are open under docket FDA-2026-D-13432, with a deadline of Jan. 11 or 12, 2027 depending on the source. Finalization would follow the comment period, but no timeline appears in the items. · yesterday

Forces, money & more Biotech

Activity · 30 days back, 14 ahead

Total
1
Peak/day
1Nov 11
7d
0▼1
Next
—
Σ/day1
Hill1
Contracts0
News0

In the News

0 articles in the past 24 hours
0

No the news on this issue yet.

On the Hill

Congress, the White House and agencies
5

Contracts

Solicitations, SBIR topics, grants and awards
3

Analytics cookies help us see how the site is used. They only run if you accept. Privacy Policy